Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,719Revenue $M7,146Net Margin (%)10.9Z-Score3.0
Enterprise Value $M12,560EPS $5.5Operating Margin %19.9F-Score6
P/E(ttm))11.6Cash Flow Per Share $5.2Pre-tax Margin (%)18.1Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %8.4Quick Ratio1.1Cash flow > EarningsN
Price/Sales1.35-y EBITDA Growth Rate %6.8Current Ratio1.2Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %34.0ROA % (ttm)8.5Higher Current Ratio y-yY
Dividend Yield %2.1Insider Buy (3m)1ROE % (ttm)19.8Less Shares Outstanding y-yY
Payout Ratio %24.0Shares Outstanding M144ROI % (ttm)5.5Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXScott Black 2014-06-30 Buy $55.5 - $61.75
($58.56)
$ 61.064%New holding, 220 sh.220
DGXJoel Greenblatt 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 61.064%Reduce -94.26%4,384
DGXDavid Dreman 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 61.064%Reduce -26.19%35,982
DGXRay Dalio 2014-06-30 Reduce-0.03%$55.5 - $61.75
($58.56)
$ 61.064%Reduce -82.85%13,545
DGXDavid Dreman 2014-03-31 Add0.09%$50.8 - $57.99
($53.53)
$ 61.0614%Add 66.84%48,748
DGXRay Dalio 2014-03-31 Buy 0.04%$50.8 - $57.99
($53.53)
$ 61.0614%New holding, 78977 sh.78,977
DGXJoel Greenblatt 2014-03-31 Reduce-0.26%$50.8 - $57.99
($53.53)
$ 61.0614%Reduce -72.63%76,412
DGXJoel Greenblatt 2013-12-31 Add0.3%$52.79 - $63.7
($59.36)
$ 61.063%Add 533.63%279,188
DGXDavid Dreman 2013-12-31 Reduce-0.06%$52.79 - $63.7
($59.36)
$ 61.063%Reduce -28.19%29,218
DGXJoel Greenblatt 2013-09-30 Add0.03%$57.96 - $62.48
($59.81)
$ 61.062%Add 41.25%44,062
DGXRay Dalio 2013-09-30 Sold Out $57.96 - $62.48
($59.81)
$ 61.062%Sold Out0
DGXRay Dalio 2013-06-30 Buy $55.48 - $63.2
($59.57)
$ 61.062%New holding, 4598 sh.4,598
DGXJoel Greenblatt 2013-06-30 Reduce-0.16%$55.48 - $63.2
($59.57)
$ 61.062%Reduce -64.8%31,194
DGXDavid Dreman 2013-03-31 Buy 0.07%$55.42 - $61.83
($57.49)
$ 61.066%New holding, 46116 sh.46,116
DGXJoel Greenblatt 2013-03-31 Add0.06%$55.42 - $61.83
($57.49)
$ 61.066%Add 32.8%88,614
DGXVanguard Health Care Fund 2013-03-31 Sold Out -1%$55.42 - $61.83
($57.49)
$ 61.066%Sold Out0
DGXJoel Greenblatt 2012-12-31 Add0.12%$56.31 - $64.68
($59.32)
$ 61.063%Add 131.43%66,725
DGXJoel Greenblatt 2012-09-30 Reduce-0.08%$57.25 - $63.51
($60.59)
$ 61.061%Reduce -38.41%28,832
DGXJoel Greenblatt 2012-06-30 Add0.08%$53.74 - $61.77
($57.7)
$ 61.066%Add 62.64%46,812
DGXRay Dalio 2012-06-30 Sold Out -0.03%$53.74 - $61.77
($57.7)
$ 61.066%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DGX Scott Black 2014-06-3022000New Buy
DGX David Dreman 2014-06-3035,9820.020.16-26.19%
DGX Ray Dalio 2014-06-3013,5450.010.01-82.85%
DGX Joel Greenblatt 2014-06-304,38400-94.26%
Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Doherty Catherine T.SVP, Clinical Franchises 2014-08-08Sell25,000$60.121.91view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-08-04Sell14,377$61.010.43view
BRITELL JENNE KDirector 2014-07-30Sell8,000$62.37-1.76view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-07-30Sell16,384$62.51-1.98view
BALDWIN JOHN C MDDirector 2014-07-29Sell8,000$62.31-1.67view
BONGIORNO THOMAS FVP and Corporate Controller 2014-07-28Sell4,000$61.72-0.73view
ZIEGLER JOHN BDirector 2014-07-25Sell8,000$61.9-1.02view
ZIEGLER JOHN BDirector 2014-05-22Sell2,973$57.656.28view
PFEIFFER GARY MDirector 2014-05-07Sell10,000$55.959.51view
GUINAN MARKSenior Vice President & CFO 2014-05-05Buy4,000$55.5110.38view

Press Releases about DGX :

    Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    DGX: A Healthy Diagnosis Sep 24 2014 
    The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
    Bernard Horn Comments on Quest Diagnostics Aug 07 2014 
    Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 05 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S Apr 29 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 28 2014 

    More From Other Websites
    Practice Fusion to Provide Access to Electronic Laboratory Test Ordering and Reporting with Quest... Sep 25 2014
    [video] Getting Your Medical Tests Online: Pros and Cons Sep 15 2014
    Quest Diagnostics Marks 10 Years on the Dow Jones Sustainability Index Sep 12 2014
    Workforce Drug Test Positivity Rate Increases for the First Time in 10 Years, Driven by Marijuana... Sep 11 2014
    DGX, HUM And AET, 3 Health Services Stocks Pushing The Industry Lower Sep 10 2014
    More People Testing Positive for Chikungunya Virus in the U.S., Finds Study at ICAAC 2014 Sep 08 2014
    Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference Sep 04 2014
    Early Look at the Hammerstone Report (Street Rec's Roundup) Sep 03 2014
    Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According... Aug 27 2014
    Air Methods Navigates To Grow Medical Flight Business Aug 18 2014
    Quest Diagnostics Declares Quarterly Cash Dividend Aug 15 2014
    Myriad Genetics: Not as Bad as It Looks? Aug 13 2014
    Myriad Genetics Guidance Disappoints, Q4 Edges Views Aug 12 2014
    Myriad Genetics' Earnings Face 'Angelina Jolie' Comps Aug 11 2014
    QUEST DIAGNOSTICS INC Financials Aug 08 2014
    Dr. Phillip P. Chan, the CEO and President of CytoSorbents Corporation (CTSO), Interviews with The... Aug 01 2014
    QUEST DIAGNOSTICS INC Files SEC form 10-Q, Quarterly Report Jul 31 2014
    FDA To Regulate Thousands Of Cancer, Genetic, And Other Diagnostics Jul 31 2014
    [video] What's it like working with Carl Icahn? Jul 31 2014
    [video] Hologic's 3D medical breakthrough: CEO Jul 31 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK